[HTML][HTML] A review of SARS-CoV-2 variants and vaccines: viral properties, mutations, vaccine efficacy, and safety

MA Islam - Infectious Medicine, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus
disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all …

Perilaku penerapan gizi seimbang masyarakat kota binjai pada masa pandemi covid-19 tahun 2020

DM Akbar, Z Aidha - Menara Medika, 2020 - jurnal.umsb.ac.id
Gizi seimbang pada masa pandemi covid-19 sangat penting bagi pola hidup manusia
karena dengan mengkonsumsi gizi seimbang maka masyarakat dapat menjaga kesehatan …

[HTML][HTML] Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

PK Raghav, Z Mann, SK Ahluwalia… - Journal of …, 2023 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S …

Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine …

J Li, FM Huang, QL Ma, W Guo, KY Feng… - Frontiers in …, 2023 - frontiersin.org
The widely used ChAdOx1 nCoV-19 (ChAd) vector and BNT162b2 (BNT) mRNA vaccines
have been shown to induce robust immune responses. Recent studies demonstrated that …

Association between COVID-19 infection or vaccination outcomes and methylenetetrahydrofolate reductase gene polymorphism: a systematic review of the literature

I Jukic, A Heffernan, AF Schelling… - Journal of personalized …, 2023 - mdpi.com
Background: Thrombosis is a detrimental sequala of COVID-19 infection; thus, prophylactic
anti-coagulant therapy has been deemed mandatory in treatment unless serious …

Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia

NLA Megasari, LN Yamani, J Juniastuti, MI Lusida… - PeerJ, 2023 - peerj.com
Background To limit the SARS-CoV-2 transmission, the Indonesian government launched a
COVID-19 vaccination program in January 2021. Studies on the clinical treatment and …

Using machine learning methods in identifying genes associated with COVID-19 in cardiomyocytes and cardiac vascular endothelial cells

Y Xu, Q Ma, J Ren, L Chen, W Guo, K Feng, Z Zeng… - Life, 2023 - mdpi.com
Corona Virus Disease 2019 (COVID-19) not only causes respiratory system damage, but
also imposes strain on the cardiovascular system. Vascular endothelial cells and …

[HTML][HTML] Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker

P Chen, X Yang, P Wang, H He, Y Chen… - Annals of …, 2023 - ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus
causes novel coronavirus disease 2019 (COVID-19), which is characterized by pneumonia …

[HTML][HTML] Development of SARS-CoV-2 entry antivirals

M Dong, JMG Achi, R Du, L Rong, Q Cui - Cell Insight, 2024 - Elsevier
The global outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
threatened human health and public safety. The development of anti-SARS-CoV-2 therapies …

Comprehensive profiling analysis of CD209 in malignancies reveals the therapeutic implication for tumor patients infected with SARS-CoV-2

J Li, S Chen, Y Li, Z Zhu, H Huang, W Wang… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), which is known to be caused by the virus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by pneumonia …